Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Asberg

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Advances in Biochemical Psychopharmacology|January 1, 1984
Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspectsL Bertilsson, M Asberg
Psychological Reports|August 1, 1997
Psychiatric health, ethnicity and socioeconomic factors among suicides in StockholmM Ferrada-Noli, M Asberg
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1979
A new depression scale designed to be sensitive to changeS A Montgomery, M Asberg
Lakartidningen|April 15, 1992
[The man behind the test. Hermann Rorschach. His first ink-blot pictures were not received favorably]A M Carlsson, M Asberg
Lakartidningen|May 2, 1998
["Three kinds of charity" in psychiatry. All are needed when facing human psychiatric suffering]C Crafoord, L Jacobsson, M Asberg
Acta Psychiatrica Scandinavica|August 1, 1995
Temperamental vulnerability in attempted suicideP Nordström, D Schalling, M Asberg
Advances in Biochemical Psychopharmacology|January 1, 1984
CSF monoamine metabolites, depression, and suicideM Asberg, L Bertilsson, B Mårtensson
Psychiatry Research|October 1, 1982
Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluidE Rydin, D Schalling, M Asberg
Acta Psychiatrica Scandinavica|May 1, 1995
Survival analysis of suicide risk after attempted suicideP Nordström, M Samuelsson, M Asberg
Therapeutic Drug Monitoring|January 1, 1980
Monitoring tricyclic antidepressantsF Sjöqvist, L Bertilsson, M Asberg
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Advances in Biochemical Psychopharmacology|January 1, 1984
Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspectsL Bertilsson, M Asberg
Psychological Reports|August 1, 1997
Psychiatric health, ethnicity and socioeconomic factors among suicides in StockholmM Ferrada-Noli, M Asberg
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1979
A new depression scale designed to be sensitive to changeS A Montgomery, M Asberg
Lakartidningen|April 15, 1992
[The man behind the test. Hermann Rorschach. His first ink-blot pictures were not received favorably]A M Carlsson, M Asberg
Lakartidningen|May 2, 1998
["Three kinds of charity" in psychiatry. All are needed when facing human psychiatric suffering]C Crafoord, L Jacobsson, M Asberg
Acta Psychiatrica Scandinavica|August 1, 1995
Temperamental vulnerability in attempted suicideP Nordström, D Schalling, M Asberg
Advances in Biochemical Psychopharmacology|January 1, 1984
CSF monoamine metabolites, depression, and suicideM Asberg, L Bertilsson, B Mårtensson
Psychiatry Research|October 1, 1982
Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluidE Rydin, D Schalling, M Asberg
Acta Psychiatrica Scandinavica|May 1, 1995
Survival analysis of suicide risk after attempted suicideP Nordström, M Samuelsson, M Asberg
Therapeutic Drug Monitoring|January 1, 1980
Monitoring tricyclic antidepressantsF Sjöqvist, L Bertilsson, M Asberg
Pageof 14